- The shares of Eli Lilly (NYSE: LLY) have received a $293 price target from UBS. These are the details.
The shares of Eli Lilly (NYSE: LLY) have received a $293 price target from UBS. And UBS analyst Navin Jacob increased the price target on Eli Lilly from $267 while maintaining a “Neutral” rating on the shares.
In late April, Eli Lilly reported a Q1 EPS of $2.62, which was $0.49 better than analyst estimates of $2.13. And the revenue for the quarter was $7.81 billion compared to the consensus estimate of $6.68 billion.
Eli Lilly is expecting FY2022 EPS of between $8.15-$8.30, compared to the consensus of $8.19. And the company expects revenue to be between $28.8 billion and $29.3 billion compared to a consensus of $26.8 billion.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
